FDA Proposes Guidelines to Expedite Cell and Gene Therapy Development

The U.S. Food and Drug Administration has introduced draft guidance designed to speed up the creation and delivery of cell and gene therapies. This regulatory move seeks to simplify the development process for these advanced treatments. The initiative could significantly improve patient access and accelerate clinical progress.